Michael Curtis, incoming eGenesis CEO

Ex­clu­sive: En route to first xeno­trans­plan­ta­tion tri­al, eGe­n­e­sis taps new CEO weeks af­ter CMO hire

When Michael Cur­tis joined xeno­trans­plan­ta­tion start­up eGe­n­e­sis as pres­i­dent of R&D in late-2020, he knew he’d one day be­come CEO.

He and Paul Sekhri, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.